Passage Bio and Remix Therapeutics agree to all-stock merger deal Jun 24, 2026 04:06PM
Passage Bio and Remix Therapeutics Announce Merger Agreement Jun 24, 2026 04:05PM
Passage Bio Inc. (PASG) PT Lowered to $67 at Canaccord Genuity Aug 14, 2025 06:43AM
Canaccord Genuity Reiterates Buy Rating on Passage Bio Inc. (PASG) Sep 17, 2024 06:42AM
Passage Bio to Participate in Upcoming Investor Conferences Aug 6, 2024 07:00AM


Aug 1, 2023 07:00AM Passage Bio to Participate in Upcoming Investor Conferences